Science Advances | Volume 11, Issue 9
Dr. Bin Wu (Phosphorex's Board Member & Founder & CEO of Cytodigm) and Theresa Logan from Phosphorex contributed to this groundbreaking work.
Press Announcing a ground breaking collaboration of Lipidnanoparticles industry experts...
Contract Pharma | Pharma Matters Q&A interview with our CEO, Jarlath Keating
A conversation with Jarlath Keating, CEO of Phosphorex, on the future of LNPs in pharmaceutical innovation.
In recent years, lipid nanoparticles (LNPs) have emerged as a groundbreaking technology in the pharmaceutical world, revolutionizing the delivery of complex therapeutic molecules like RNA and DNA.